IMDX
Insight Molecular Diagnostics
IMDX
IMDX
39 hedge funds and large institutions have $18.1M invested in Insight Molecular Diagnostics in 2018 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 11 increasing their positions, 9 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
17% less capital invested
Capital invested by funds: $21.7M → $18.1M (-$3.61M)
67% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 9
Holders
39
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$8.33M | |
| 2 | +$61K | |
| 3 | +$37K | |
| 4 |
Janney Montgomery Scott
Philadelphia,
Pennsylvania
|
+$27K |
| 5 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
+$5.76K |
Top Sellers
| 1 | -$78K | |
| 2 | -$63.1K | |
| 3 | -$48K | |
| 4 |
TCIM
TIAA CREF Investment Management
New York
|
-$34K |
| 5 |
TA
Teachers Advisors
New York
|
-$20K |